Neuromuscular Blocking Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neuromuscular Blocking Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuromuscular Blocking Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuromuscular Blocking Drug Overall Market Size
2.1 Global Neuromuscular Blocking Drug Market Size: 2021 VS 2028
2.2 Global Neuromuscular Blocking Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Neuromuscular Blocking Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Neuromuscular Blocking Drug Players in Global Market
3.2 Top Global Neuromuscular Blocking Drug Companies Ranked by Revenue
3.3 Global Neuromuscular Blocking Drug Revenue by Companies
3.4 Global Neuromuscular Blocking Drug Sales by Companies
3.5 Global Neuromuscular Blocking Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Neuromuscular Blocking Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Neuromuscular Blocking Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neuromuscular Blocking Drug Players in Global Market
3.8.1 List of Global Tier 1 Neuromuscular Blocking Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Neuromuscular Blocking Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuromuscular Blocking Drug Market Size Markets, 2021 & 2028
4.1.2 Non-polarizing Agents
4.1.3 Depolarizing Agents
4.2 By Type - Global Neuromuscular Blocking Drug Revenue & Forecasts
4.2.1 By Type - Global Neuromuscular Blocking Drug Revenue, 2017-2022
4.2.2 By Type - Global Neuromuscular Blocking Drug Revenue, 2023-2028
4.2.3 By Type - Global Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Neuromuscular Blocking Drug Sales & Forecasts
4.3.1 By Type - Global Neuromuscular Blocking Drug Sales, 2017-2022
4.3.2 By Type - Global Neuromuscular Blocking Drug Sales, 2023-2028
4.3.3 By Type - Global Neuromuscular Blocking Drug Sales Market Share, 2017-2028
4.4 By Type - Global Neuromuscular Blocking Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Neuromuscular Blocking Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Neuromuscular Blocking Drug Revenue & Forecasts
5.2.1 By Application - Global Neuromuscular Blocking Drug Revenue, 2017-2022
5.2.2 By Application - Global Neuromuscular Blocking Drug Revenue, 2023-2028
5.2.3 By Application - Global Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Neuromuscular Blocking Drug Sales & Forecasts
5.3.1 By Application - Global Neuromuscular Blocking Drug Sales, 2017-2022
5.3.2 By Application - Global Neuromuscular Blocking Drug Sales, 2023-2028
5.3.3 By Application - Global Neuromuscular Blocking Drug Sales Market Share, 2017-2028
5.4 By Application - Global Neuromuscular Blocking Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Neuromuscular Blocking Drug Market Size, 2021 & 2028
6.2 By Region - Global Neuromuscular Blocking Drug Revenue & Forecasts
6.2.1 By Region - Global Neuromuscular Blocking Drug Revenue, 2017-2022
6.2.2 By Region - Global Neuromuscular Blocking Drug Revenue, 2023-2028
6.2.3 By Region - Global Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Neuromuscular Blocking Drug Sales & Forecasts
6.3.1 By Region - Global Neuromuscular Blocking Drug Sales, 2017-2022
6.3.2 By Region - Global Neuromuscular Blocking Drug Sales, 2023-2028
6.3.3 By Region - Global Neuromuscular Blocking Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Neuromuscular Blocking Drug Revenue, 2017-2028
6.4.2 By Country - North America Neuromuscular Blocking Drug Sales, 2017-2028
6.4.3 US Neuromuscular Blocking Drug Market Size, 2017-2028
6.4.4 Canada Neuromuscular Blocking Drug Market Size, 2017-2028
6.4.5 Mexico Neuromuscular Blocking Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Neuromuscular Blocking Drug Revenue, 2017-2028
6.5.2 By Country - Europe Neuromuscular Blocking Drug Sales, 2017-2028
6.5.3 Germany Neuromuscular Blocking Drug Market Size, 2017-2028
6.5.4 France Neuromuscular Blocking Drug Market Size, 2017-2028
6.5.5 U.K. Neuromuscular Blocking Drug Market Size, 2017-2028
6.5.6 Italy Neuromuscular Blocking Drug Market Size, 2017-2028
6.5.7 Russia Neuromuscular Blocking Drug Market Size, 2017-2028
6.5.8 Nordic Countries Neuromuscular Blocking Drug Market Size, 2017-2028
6.5.9 Benelux Neuromuscular Blocking Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Neuromuscular Blocking Drug Revenue, 2017-2028
6.6.2 By Region - Asia Neuromuscular Blocking Drug Sales, 2017-2028
6.6.3 China Neuromuscular Blocking Drug Market Size, 2017-2028
6.6.4 Japan Neuromuscular Blocking Drug Market Size, 2017-2028
6.6.5 South Korea Neuromuscular Blocking Drug Market Size, 2017-2028
6.6.6 Southeast Asia Neuromuscular Blocking Drug Market Size, 2017-2028
6.6.7 India Neuromuscular Blocking Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Neuromuscular Blocking Drug Revenue, 2017-2028
6.7.2 By Country - South America Neuromuscular Blocking Drug Sales, 2017-2028
6.7.3 Brazil Neuromuscular Blocking Drug Market Size, 2017-2028
6.7.4 Argentina Neuromuscular Blocking Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neuromuscular Blocking Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Neuromuscular Blocking Drug Sales, 2017-2028
6.8.3 Turkey Neuromuscular Blocking Drug Market Size, 2017-2028
6.8.4 Israel Neuromuscular Blocking Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Neuromuscular Blocking Drug Market Size, 2017-2028
6.8.6 UAE Neuromuscular Blocking Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Hikma Pharmaceuticals
7.1.1 Hikma Pharmaceuticals Corporate Summary
7.1.2 Hikma Pharmaceuticals Business Overview
7.1.3 Hikma Pharmaceuticals Neuromuscular Blocking Drug Major Product Offerings
7.1.4 Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales and Revenue in Global (2017-2022)
7.1.5 Hikma Pharmaceuticals Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Neuromuscular Blocking Drug Major Product Offerings
7.2.4 Merck Neuromuscular Blocking Drug Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Neuromuscular Blocking Drug Major Product Offerings
7.3.4 Novartis Neuromuscular Blocking Drug Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Neuromuscular Blocking Drug Major Product Offerings
7.4.4 Bayer Neuromuscular Blocking Drug Sales and Revenue in Global (2017-2022)
7.4.5 Bayer Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Neuromuscular Blocking Drug Major Product Offerings
7.5.4 Pfizer Neuromuscular Blocking Drug Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 AbbVie
7.6.1 AbbVie Corporate Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Neuromuscular Blocking Drug Major Product Offerings
7.6.4 AbbVie Neuromuscular Blocking Drug Sales and Revenue in Global (2017-2022)
7.6.5 AbbVie Key News
7.7 GSK
7.7.1 GSK Corporate Summary
7.7.2 GSK Business Overview
7.7.3 GSK Neuromuscular Blocking Drug Major Product Offerings
7.7.4 GSK Neuromuscular Blocking Drug Sales and Revenue in Global (2017-2022)
7.7.5 GSK Key News
8 Global Neuromuscular Blocking Drug Production Capacity, Analysis
8.1 Global Neuromuscular Blocking Drug Production Capacity, 2017-2028
8.2 Neuromuscular Blocking Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Neuromuscular Blocking Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neuromuscular Blocking Drug Supply Chain Analysis
10.1 Neuromuscular Blocking Drug Industry Value Chain
10.2 Neuromuscular Blocking Drug Upstream Market
10.3 Neuromuscular Blocking Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neuromuscular Blocking Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Neuromuscular Blocking Drug in Global Market
Table 2. Top Neuromuscular Blocking Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Neuromuscular Blocking Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Neuromuscular Blocking Drug Revenue Share by Companies, 2017-2022
Table 5. Global Neuromuscular Blocking Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Neuromuscular Blocking Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Neuromuscular Blocking Drug Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Neuromuscular Blocking Drug Product Type
Table 9. List of Global Tier 1 Neuromuscular Blocking Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuromuscular Blocking Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Neuromuscular Blocking Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Neuromuscular Blocking Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Neuromuscular Blocking Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Neuromuscular Blocking Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Neuromuscular Blocking Drug Sales (K Units), 2023-2028
Table 16. By Application ? Global Neuromuscular Blocking Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Neuromuscular Blocking Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Neuromuscular Blocking Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Neuromuscular Blocking Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Neuromuscular Blocking Drug Sales (K Units), 2023-2028
Table 21. By Region ? Global Neuromuscular Blocking Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Neuromuscular Blocking Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Neuromuscular Blocking Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Neuromuscular Blocking Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Neuromuscular Blocking Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Neuromuscular Blocking Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Neuromuscular Blocking Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Neuromuscular Blocking Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Neuromuscular Blocking Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Neuromuscular Blocking Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Neuromuscular Blocking Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Neuromuscular Blocking Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Neuromuscular Blocking Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Neuromuscular Blocking Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Neuromuscular Blocking Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Neuromuscular Blocking Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Neuromuscular Blocking Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Neuromuscular Blocking Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Neuromuscular Blocking Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Neuromuscular Blocking Drug Sales, (K Units), 2023-2028
Table 46. Hikma Pharmaceuticals Corporate Summary
Table 47. Hikma Pharmaceuticals Neuromuscular Blocking Drug Product Offerings
Table 48. Hikma Pharmaceuticals Neuromuscular Blocking Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Neuromuscular Blocking Drug Product Offerings
Table 51. Merck Neuromuscular Blocking Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Neuromuscular Blocking Drug Product Offerings
Table 54. Novartis Neuromuscular Blocking Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Bayer Corporate Summary
Table 56. Bayer Neuromuscular Blocking Drug Product Offerings
Table 57. Bayer Neuromuscular Blocking Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Neuromuscular Blocking Drug Product Offerings
Table 60. Pfizer Neuromuscular Blocking Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. AbbVie Corporate Summary
Table 62. AbbVie Neuromuscular Blocking Drug Product Offerings
Table 63. AbbVie Neuromuscular Blocking Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. GSK Corporate Summary
Table 65. GSK Neuromuscular Blocking Drug Product Offerings
Table 66. GSK Neuromuscular Blocking Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Neuromuscular Blocking Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Neuromuscular Blocking Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Neuromuscular Blocking Drug Production by Region, 2017-2022 (K Units)
Table 70. Global Neuromuscular Blocking Drug Production by Region, 2023-2028 (K Units)
Table 71. Neuromuscular Blocking Drug Market Opportunities & Trends in Global Market
Table 72. Neuromuscular Blocking Drug Market Drivers in Global Market
Table 73. Neuromuscular Blocking Drug Market Restraints in Global Market
Table 74. Neuromuscular Blocking Drug Raw Materials
Table 75. Neuromuscular Blocking Drug Raw Materials Suppliers in Global Market
Table 76. Typical Neuromuscular Blocking Drug Downstream
Table 77. Neuromuscular Blocking Drug Downstream Clients in Global Market
Table 78. Neuromuscular Blocking Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Neuromuscular Blocking Drug Segment by Type
Figure 2. Neuromuscular Blocking Drug Segment by Application
Figure 3. Global Neuromuscular Blocking Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neuromuscular Blocking Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neuromuscular Blocking Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Neuromuscular Blocking Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Neuromuscular Blocking Drug Revenue in 2021
Figure 9. By Type - Global Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Neuromuscular Blocking Drug Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Neuromuscular Blocking Drug Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 19. US Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 24. Germany Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 33. China Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 40. Brazil Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Neuromuscular Blocking Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Neuromuscular Blocking Drug Sales Market Share, 2017-2028
Figure 44. Turkey Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Neuromuscular Blocking Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Neuromuscular Blocking Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Neuromuscular Blocking Drug by Region, 2021 VS 2028
Figure 50. Neuromuscular Blocking Drug Industry Value Chain
Figure 51. Marketing Channels
